Key Points
- Trupanion CFO Fawwad Qureshi sold 6,177 shares on May 27 at an average price of $22.18, totaling about $137,006. The sale reduced his direct ownership by 74.8% and was made to cover tax withholding tied to vesting equity awards.
- The stock was down 0.8% and opened at $21.69, near its 52-week low of $21.16. Trupanion’s market cap was about $946 million, with the shares trading below both their 50-day and 200-day moving averages.
- Trupanion beat quarterly earnings expectations, reporting $0.11 EPS versus the $0.07 consensus and revenue of $384.05 million, up 12.3% year over year. Despite the beat, analysts currently rate the stock a consensus Hold with an average price target of $42.25.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 491 shares of the stock in a transaction on Monday, May 25th. The stock was sold at an average price of $21.86, for a total value of $10,733.26. Following the sale, the chief executive officer owned 176,379 shares of the company's stock, valued at approximately $3,855,644.94. This represents a 0.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Trupanion Price Performance
Shares of NASDAQ:TRUP opened at $21.69 on Thursday. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The business has a fifty day simple moving average of $25.08 and a 200 day simple moving average of $30.52. The firm has a market cap of $946.12 million, a price-to-earnings ratio of 36.76 and a beta of 1.49.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The business had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period last year, the company earned ($0.03) earnings per share. Trupanion's quarterly revenue was up 12.3% compared to the same quarter last year. As a group, sell-side analysts predict that Trupanion, Inc. will post 0.53 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Several hedge funds have recently bought and sold shares of TRUP. Federated Hermes Inc. acquired a new position in Trupanion during the third quarter worth $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Trupanion during the third quarter worth $39,000. Parallel Advisors LLC grew its position in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock valued at $47,000 after purchasing an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. bought a new position in shares of Trupanion in the fourth quarter worth about $64,000. Finally, Kelleher Financial Advisors acquired a new position in shares of Trupanion during the 3rd quarter worth about $74,000.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. Stifel Nicolaus lowered their target price on shares of Trupanion from $35.00 to $31.00 and set a "hold" rating on the stock in a research report on Tuesday, March 31st. Cantor Fitzgerald lowered their target price on shares of Trupanion from $42.00 to $34.00 and set a "neutral" rating on the stock in a research report on Thursday, April 9th. Bank of America lowered their target price on shares of Trupanion from $63.00 to $59.00 and set a "buy" rating on the stock in a research report on Tuesday, April 14th. Weiss Ratings downgraded shares of Trupanion from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, March 4th. Finally, Piper Sandler lowered their target price on shares of Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a research report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Trupanion presently has an average rating of "Hold" and a consensus price target of $42.25.
Check Out Our Latest Stock Analysis on Trupanion
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
